HEATHER PRESSON: Open Payments
NPI 1427545664 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 19 payments from 12 companies in 2025. Trend: 2023 $922 · 2024 $1,517 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $218 |
| Ardelyx, Inc. | 3 | $187 |
| KYOWA KIRIN, INC. | 1 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Alexion Pharmaceuticals, Inc. | 1 | $27 |
| AKEBIA THERAPEUTICS INC | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| Apellis Pharmaceuticals, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Boston Scientific Corporation | 1 | $19 |
Products named: Vanrafia, XPHOZAH 30 MG, IBSRELA, JYNARQUE, ULTOMIRIS, Auryxia, JARDIANCE, ENROUTE Transcarotid Neuroprotection System.
Industry payments across FL — which companies pay providers there.
